SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-18-007232
Filing Date
2018-06-05
Accepted
2018-06-05 11:32:39
Documents
6
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO ANNUAL REPORT f10k2017a1_wizepharmainc.htm 10-K/A 145291
2 MEMORANDUM OF UNDERSTANDING BY AND BETWEEN WIZE PHARMA LTD. AND RESDEVCO RESEARC f10k2017a1ex10-44_wizepharma.htm EX-10.44 47417
3 CERTIFICATION f10k2017a1ex31-1_wizepharma.htm EX-31.1 15942
4 CERTIFICATION f10k2017a1ex31-2_wizepharma.htm EX-31.2 15060
5 CERTIFICATION f10k2017a1ex32-1_wizepharma.htm EX-32.1 7602
6 CERTIFICATION f10k2017a1ex32-2_wizepharma.htm EX-32.2 7732
  Complete submission text file 0001213900-18-007232.txt   240194
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52545 | Film No.: 18880392
SIC: 2834 Pharmaceutical Preparations